Effect of Conjugated Linoleic Acid Supplement on Body Composition

• Status: Completed
• Trial end date: 2005-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this clinical trial is to examine the effects of a low and high dose of conjugated linoleic acid supplement on body composition in obese humans. Individuals with a body mass index between 30 and 35kg/m2 are randomized to receive either placebo, 3.2gCLA, or 6.4g CLA daily for twelve weeks. Changes in body composition, weight, and clinical laboratory values are compared between the three groups.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of North Carolina
• Collaborator: Cognis

Criteria

Inclusion Criteria:

• BMI between 30 and 35 kg/m2

Exclusion Criteria:

• history of chronic disease

• food allergies or intolerances

• drug therapy for diagnosed disease or lipid-lowering

• use of weight-lowering medication or diet

• use of tobacco products

• current or planned pregnancy

• use of CLA supplement in previous 3 months

• current substance abuse

• abnormal clinical laboratory values